Your cart
$0.00 (0 items)
We aspire to build a strong relationship with our customers and we offer discounts for repeat orders!
Perform search
Categories list

Antivirals

Famvir

Famvir

Famciclovir 250mg
Per pill
$3.62
+ More info » Buy now!
Lamprene

Lamprene

Clofazimine 50mg
Per pill
$3.33
+ More info » Buy now!
Rebetol

Rebetol

Ribavirin 200mg
Per pill
$9.00
+ More info » Buy now!
Relenza

Relenza

Zanamivir 5mg
Per item
$199.98
+ More info » Buy now!
Symmetrel

Symmetrel

Amantadine 100mg
Per pill
$1.36
+ More info » Buy now!
Tamiflu

Tamiflu

Oseltamivir 75mg
Per pill
$10.00
+ More info » Buy now!
Valtrex

Valtrex

Valacyclovir 0.5/1g
Per pill
$6.28
+ More info » Buy now!
Zovirax

Zovirax

Acyclovir 200/400/800mg
Per pill
$0.78
+ More info » Buy now!

I,HAVE RECEIVED THE PRODUCT. I tested it out and my date was tottally satisfied.She wants to get together now twice a week instead of only once.thank you for a life changing product.I ALLREADY enjoy my life but to bring joy to her is a great gift.plus with the dollars we save we can afford to go out. - satisfied customer stewart

Latest News

  • Patients' Expectations About New HCV Direct-Acting Antivirals Often Unrealistic - Gastroenterology & Endoscopy News

    Gastroenterology & Endoscopy NewsPatients' Expectations About New HCV Direct-Acting Antivirals Often UnrealisticGastroenterology & Endoscopy Newsby Christina Frangou San Francisco—Soon after the FDA approved two direct-acting antiviral agents (DAAs) last spring for treating infection with hepatitis C virus (HCV), a 57-year-old black man came to see gastroenterologist Andrew Muir, MD.

  • Patients relapse after Gilead hepatitis C treatment - PMLiVE

    Patients relapse after Gilead hepatitis C treatmentPMLiVEGS-7977 was one of the main assets behind Gilead's $10.

  • UK company, OnlineClinic, expands services for STI's, travel medicine - Examiner.com

    UK company, OnlineClinic, expands services for STI's, travel medicineExaminer.

  • Hepatitis C Study Drug Fails; Most Patients Relapse - Medscape

    Hepatitis C Study Drug Fails; Most Patients RelapseMedscapeNull responders represent 'a challenging patient population to cure,' said Norbert Bischofberger, PhD, Gilead's chief scientific officer, noting that additional direct-acting antivirals or an extended duration of therapy may be needed to achieve better .

  • Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide ... - MarketWatch (press release)

    CitybizlistIdenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide .

Home We accept: